Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 27, 2019 Off

IMFINZI® (durvalumab) Improves Overall Survival at Interim Analysis in the Phase III CASPIAN Trial in 1st-Line Extensive-Stage Small Cell Lung Cancer

By BusinessWire

Trial showed statistically-significant and clinically meaningful benefit in patients with the most aggressive type of lung cancer WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca…

June 27, 2019 Off

Global Cancer Stem Cell Therapeutics Market Report 2019-2023 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Cancer Stem Cell Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The global cancer stem…

June 27, 2019 Off

Global Cancer Stem Cell Therapeutics Market Report 2019-2023 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Cancer Stem Cell Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The global cancer stem…

June 27, 2019 Off

DILIsym Releases NAFLDsym® Version 2A

By BusinessWire

Substantial update of NAFLD drug efficacy software offers a broad range of pathophysiology and over a thousand simulated patients for…

June 27, 2019 Off

DILIsym Releases NAFLDsym® Version 2A

By BusinessWire

Substantial update of NAFLD drug efficacy software offers a broad range of pathophysiology and over a thousand simulated patients for…

June 27, 2019 Off

Catabasis Pharmaceuticals Provides Update on Global Phase 3 PolarisDMD Trial for Edasalonexent at Parent Project Muscular Dystrophy 25th Annual Conference

By BusinessWire

— Patient Identification Nearing Completion for Global Phase 3 PolarisDMD Trial for Edasalonexent in Duchenne Muscular Dystrophy — CAMBRIDGE, Mass.–(BUSINESS…

June 27, 2019 Off

Xeris Pharmaceuticals Doses First Patient in Phase 2 Trial Evaluating Its Developmental Ready-to-use Glucagon in Patients at Risk From Hypoglycemia Following Bariatric Surgery

By BusinessWire

CHICAGO–(BUSINESS WIRE)–Xeris Pharmaceuticals, Inc. (NASDAQ:XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable…

June 27, 2019 Off

Vaxess Technologies Closes Final Tranche of $8.2 Million Series A and Appoints Dr. Purnanand Sarma to the Board

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vaxess Technologies, a biotechnology company redefining drug delivery with the silk-powered MIMIX smart release patch, today announced it…

June 27, 2019 Off

Takeda Announces the Publication of Its Annual Report on Form 20-F for FY2018

By BusinessWire

OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO:4502/NYSE:TAK) hereby announces that it has filed its Annual Report on Form 20-F…

June 27, 2019 Off

Walgreens Boots Alliance Reports Fiscal 2019 Third Quarter Results

By BusinessWire

Third quarter highlights, year-over-year Sales increased 0.7 percent to $34.6 billion Operating income decreased 24.7 percent to $1.2 billion; Adjusted…

Posts pagination

Previous 1 … 3,041 3,042 3,043 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine